| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/2008 | CA2670603A1 Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| 06/05/2008 | CA2670583A1 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 06/05/2008 | CA2670460A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | CA2670445A1 Binding members for interleukin-6 |
| 06/05/2008 | CA2668800A1 Tes7 and antibodies that bind thereto |
| 06/05/2008 | CA2668570A1 Immunization protocol against the 4 dengue serotypes |
| 06/05/2008 | CA2667485A1 Methods of disrupting quorum sensing to affect microbial population cell density |
| 06/05/2008 | CA2666905A1 Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
| 06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
| 06/04/2008 | EP1927600A1 Homogeneous preparations of IL-28 and IL-29 |
| 06/04/2008 | EP1927598A1 Vaccine |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV) |
| 06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
| 06/04/2008 | EP1926813A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 06/04/2008 | EP1926752A2 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 06/04/2008 | EP1926751A1 Method for generating f(ab')2 antibody fragments |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1926496A1 Pcv-2 vaccine |
| 06/04/2008 | EP1926495A2 Therapeutic use of outer shigella protein f (os pf) |
| 06/04/2008 | EP1606633B1 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 06/04/2008 | EP1597589B1 Diagnostics and therapeutics for haematological diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1322327B1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 06/04/2008 | EP1308168B1 Novel remedies for cancer |
| 06/04/2008 | EP1195162B1 Vaccine preparation containing fatty acid as a constituent |
| 06/04/2008 | EP1185658B1 Novel compounds from moraxella catarrhalis |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1028749B1 Enterococcus antigens and vaccines |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP0990703B1 Novel polypeptide, dna encoding the same and use thereof |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101194012A Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 06/04/2008 | CN101193917A Anti-MAdCAM antibody compositions |
| 06/04/2008 | CN101193916A Anti-integrin immunoconjugates, methods and uses |
| 06/04/2008 | CN101193655A Vaccine against pandemic strains of influenza viruses |
| 06/04/2008 | CN101193654A Antigen conjugates and uses thereof |
| 06/04/2008 | CN101193653A Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 06/04/2008 | CN101190332A Vibrio anguilarum oil oral-emulsified bivalent vaccine and preparation thereof |
| 06/04/2008 | CN100392405C Pesticide sevin artificial antigen and antibody and preparation method and application thereof |
| 06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
| 06/04/2008 | CN100392085C Vaccines |
| 06/04/2008 | CN100392084C Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
| 06/04/2008 | CN100392083C DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector |
| 06/04/2008 | CN100392082C Conserved neisserial antigens |
| 06/04/2008 | CN100392074C Dendritic cell tumor vaccine and its preparation and use |
| 06/04/2008 | CN100392067C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 06/04/2008 | CN100391980C Antitumour multitarget composite antigen, its coding gene and application |
| 06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391976C High efficiency low poison immune toxin and its preparation method and application |
| 06/04/2008 | CN100391975C Human source anti- tetanus exotoxin antibody and preparation method and use thereof |
| 06/04/2008 | CN100391970C DNA sequence and recombinant production of the grass pollen allergen Phl p4 |
| 06/04/2008 | CN100391543C Non-viral gene delivery system |
| 06/04/2008 | CN100391542C Composition for delivering genes to antigen presenting cells of the skin and its use |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391536C Therapeutic vaccine composition for hepatitis B |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/04/2008 | CA2610295A1 Gender selection with the use of antibodies |
| 06/04/2008 | CA2568512A1 Gender selection with the use of antibodies |
| 06/03/2008 | US7381817 LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 06/03/2008 | US7381809 Compositions and methods for the treatment of immune related diseases |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381802 Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381793 Extracellular matrix-binding proteins from Staphylococcus aureus |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381711 Substances for preventing and treating autoimmune diseases |
| 06/03/2008 | US7381710 Nucleic acid comprising a sequence encoding promyelocytic leukemia retinoic acid receptor alpha and a non-immunosuppressive inducer of tumor cell apoptosis which is arsenic; all-trans, 9-cis or 13-cis retinoic acid; or 4 allopurinol-l-ribonucleoside |
| 06/03/2008 | US7381700 with botulinum toxin |
| 06/03/2008 | US7381563 Treating peripherial blood mononuclear cells with a suppressive composition for a time sufficient to induce T cell tolerance; and introducing said cells to said patient. |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381524 Using immunoglobulin specific to turkey astrovirus capsid protein as tool for detecting single-stranded RNA viral infection in avians; immunodiagnostics |
| 06/03/2008 | US7381425 Preservation of bioactive materials by freeze dried foam |
| 06/03/2008 | US7381414 Mycoplasma vaccine, method of making, and application thereof |
| 06/03/2008 | US7381413 Methods and products related to metabolic interactions in disease |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | US7381410 Monoclonal antibodies that bind to epitope and inhibit clustering or phosphorylation between EphB4 and Ephrin B2 |
| 06/03/2008 | US7381409 Immunoglobulin specific to transforming growth factor binding protein for use as tool in prevention and treatment of osteoporosis and bone disorders |
| 06/03/2008 | US7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 06/03/2008 | US7381407 Detecting binding to epitope; use in immunoassays, imaging, diagnosis and treatment of cancer |
| 06/03/2008 | US7381405 Stimulating peripheral blood mononuclear cells in vitro with antigen, transducing with retroviral vector and reintroducing into patient |
| 06/03/2008 | CA2558659C Genetically engineered canary poxvirus-based vaccine strain |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2244664C Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 06/03/2008 | CA2243633C Isolated polypeptide for the skin and its use |
| 06/03/2008 | CA2186269C Wound healing |
| 06/03/2008 | CA2134835C Live in ovo vaccine |
| 06/03/2008 | CA2106978C Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 05/29/2008 | WO2008064306A2 Methods and compositions relating to islet cell neogenesis |
| 05/29/2008 | WO2008064292A2 Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof |
| 05/29/2008 | WO2008064208A2 Methods and systems for accelerating the generation of methane from a biomass |
| 05/29/2008 | WO2008064072A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 05/29/2008 | WO2008063996A2 Therapeutic targeting of escort proteins |
| 05/29/2008 | WO2008063982A2 High mannose glycoprotein epitopes |